Clinical Edge Journal Scan

Personalized topical therapy utilizing protective commensal microbes shows promise in atopic dermatitis


 

Key clinical point: A topical cream containing cultured autologous antimicrobial-producing coagulase-negative strain of Staphylococcus (CoNS-AM+) safely decreased Staphylococcus aureus colonization and improved disease severity in patients with atopic dermatitis (AD).

Major finding: At the end of treatment, CoNS-AM+ reduced S. aureus colonization on lesioned skin by 99.2% compared with the vehicle (mean of log10 ratio to baseline, −1.702 vs 0.671; P = .01), which persisted even 4 days after treatment ( P = .03). On day 11, Eczema Area and Severity Index scores improved significantly in patients receiving CoNS-AM+ vs vehicle ( P = .04). No serious adverse events were recorded in either group.

Study details: This was a double-blind, vehicle-controlled randomized clinical trial of 11 adult patients with moderate-to-severe AD randomly assigned to either CoNS-AM+ (n=5) or the vehicle (n=6).

Disclosures: This work was supported by grants from the National Institute of Health. Dr. Nakatsuji, Dr. Gallo, and Dr. Shafiq reported receiving grants and/or consulting fees from and holding patent/pending patent, and/or holding equity in various sources.

Source: Nakatsuji T et al. JAMA Dermatol. 2021 Jun 16. doi: 10.1001/jamadermatol.2021.1311.

Recommended Reading

How well do JAK inhibitors work for atopic dermatitis?
MDedge Dermatology
Musical instruments can throw skin out of tune
MDedge Dermatology
There’s a much safer food allergy immunotherapy – why don’t more doctors offer it?
MDedge Dermatology
Direct-care allergy clinic specializes in sublingual immunotherapy
MDedge Dermatology
Sublingual immunotherapy: Where does it stand?
MDedge Dermatology
Proposed classification framework for atopic dermatitis unveiled
MDedge Dermatology
UV light linked to prevention of allergic disease in infants
MDedge Dermatology
‘Gold cards’ allow Texas docs to skip prior authorizations
MDedge Dermatology
No link between childhood vaccinations and allergies or asthma
MDedge Dermatology
Common outcome measures for AD lack adequate reporting of race, skin tone
MDedge Dermatology